4 min read
Promoting Diversity for Translational Success
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like...
Insights on increasing the translational value of your preclinical development program.
Apr 4, 2024by MD Biosciences
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like...
Mar 27, 2024by MD Biosciences
Increase value early in drug development with Biomarkers
Biomarkers have emerged as transformative tools in...
Mar 18, 2024by MD Biosciences
The goal of the preclinical development process is to help predict clinical efficacy, emphasizing the importance of...
Mar 5, 2024by MD Biosciences
HTX-011 Breakthrough in Pain Management
ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved
Mar 5, 2024by MD Biosciences
It is important to bridge the gap between lab findings and clinical applications using translational models, ensuring...